At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 100 enrolled
Drug / intervention
SCORPIO™device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
SCORPIO™ Posterior Stabilized Versus Posterior Retained Total Knee Arthroplasties: Long-term Functional and Radiographic Outcome
In Brief
A Phase 4 clinical trial evaluating SCORPIO™ for Arthroplasty, Replacement, Knee and Knee Arthroplasty, Total. Completed, enrolled 100 participants across 1 site.
Detailed Summary
This randomized clinical trial (RCT) examined 10 year outcomes comparing SCORPIO™ Posterior Cruciate Substituting (PCS) versus Posterior Cruciate Retaining (PCR) Total Knee Arthroplasty (TKA) as the primary outcome.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesCanada
Collaborators--
Timeline
Phase 4CompletedFinished
19992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartFeb 1999
Primary CompletionMay 2013
First PostedApr 2015
TodayJul 2026
First PostedApr 29, 2015
Enrollment StartFeb 1, 1999
Primary CompletionMay 1, 2013
TodayJul 2, 2026
Enrollment to primary: 14.3 yearsPosted 11.2 years ago
Interventions
SCORPIO™device
subjects randomized at surgery to receive 1 of the 2 specified implants